SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-361425
Filing Date
2013-09-09
Accepted
2013-09-09 16:10:18
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d572263d10q.htm 10-Q 635485
2 EX-31.1 d572263dex311.htm EX-31.1 6924
3 EX-31.2 d572263dex312.htm EX-31.2 7271
4 EX-32.1 d572263dex321.htm EX-32.1 3850
5 EX-32.2 d572263dex322.htm EX-32.2 4229
  Complete submission text file 0001193125-13-361425.txt   6680587

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20130630.xml EX-101.INS 581505
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20130630.xsd EX-101.SCH 34247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20130630_cal.xml EX-101.CAL 49161
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20130630_def.xml EX-101.DEF 143055
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20130630_lab.xml EX-101.LAB 316503
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20130630_pre.xml EX-101.PRE 237927
Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 131085750
SIC: 2834 Pharmaceutical Preparations